SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-19-031925
Filing Date
2019-06-21
Accepted
2019-06-21 17:10:28
Documents
2
Period of Report
2019-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tv524051_8ka.htm 8-K/A 21124
2 EXHIBIT 1.1 tv524051_ex1-1.htm EX-1.1 186051
  Complete submission text file 0001144204-19-031925.txt   208587
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-31326 | Film No.: 19912339
SIC: 8731 Services-Commercial Physical & Biological Research